News
7h
HealthDay on MSNPfizer Ends Testing of Obesity Pill After Possible Liver InjuryKey Takeaways A pill to treat obesity caused liver injury in a clinical trialPfizer said it will stop developing the drug, called danuglipron, as a result Other alternatives to injectable obesity ...
Medications like Ozempic, Wegovy, and Zepbound have helped many Americans lose weight, but there are still some misconceptions about these medications and metabolic health. Centre Spring MD founder ...
People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...
12h
Best Life on MSNResearchers Say This Popular Weight-Loss Drug Can Keep You Slim for 3 Years and CountingIt's probably safe to say that weight-loss drugs aren't going anywhere any time soon. According to the most recent data, six percent of American adults, or roughly 16 million people, take such ...
Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing.
Mounjaro's launch of a weight-loss drug has sparked interest amongst the people of India despite the high price. Experts believe that making the drug locally available would help to reduce the black ...
Mounjaro, a once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.86) for a 5 milligram ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results